Home Health Care News April 24, 2024
Andrew Donlan

Both home health care and Medicare Advantage (MA) are currently in rough rate environments. But Humana Inc. (NYSE: HUM) leaders believe in the company’s ability to continue growing MA membership with solid margins, partly by leaning into CenterWell Home Health and its other provider assets.

Earlier this month, the Centers for Medicare & Medicaid Services (CMS) finalized what MA plans considered to be an underwhelming – though unsurprising – payment rule for 2025.

“I [want to] further emphasize that we continue to believe there is strong bipartisan support for the MA program, and that the strong core fundamentals and growth outlook for MA and value-based care remain intact,” Humana CEO Bruce Broussard said on the company’s first-quarter earnings call Wednesday....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare Advantage, Payer
AI-driven prior authorizations: an opportunity for advancing health equity
Navigating the Complexities of Payment for Genetic Testing
Change Healthcare vows to 'fix this'
Oscar Health records first quarterly net profit, exceeds EPS expectations
3 Payer Recoils In Medicare Advantage

Share This Article